Back to Browse Journals » International Journal of Women's Health » Volume 1

Tinidazole in the treatment of bacterial vaginosis

Authors Nicola R Armstrong, Janet D Wilson

Published Date June 2009 Volume 2009:1 Pages 59—65

DOI http://dx.doi.org/10.2147/IJWH.S4455

Published 25 June 2009

Nicola R Armstrong1, Janet D Wilson2

1Department of Infectious Diseases and Sexual Health, Trinity Centre, Bradford, UK; 2The Centre for Sexual Health, The General Infirmary at Leeds, Leeds, UK

Abstract: Bacterial vaginosis (BV) is the commonest cause of vaginal discharge in women of childbearing age. Oral metronidazole has long been established as an effective therapy in the treatment of BV. However, adverse effects due to metronidazole are frequent and this may lead to problems with adherence to a 7-day course of treatment and subsequently result in treatment failure. Oral tinidazole has been used to treat bacterial vaginosis for over 25 years but in a number of different dosage regimens. Placebo controlled trials have consistently shown increases in cure rate with tinidazole. Longer courses of treatment (eg, 1 g daily for 5 days) appear to be more effective than a 2 g oral single dose. Comparative studies suggest that oral tinidazole is equivalent to oral metronidazole, intravaginal clindamycin cream, and intravaginal metronidazole tablets, in efficacy in treating BV. However, tinidazole has a more favorable side effect profile than oral metronidazole notably with better gastrointestinal tolerability and less metallic taste. Bacterial vaginosis is associated with high rates of recurrence and appropriate management of such recurrences can prove difficult. Recurrent BV has been linked with persistence of Gardnerella vaginalis after treatment; however the clinical implications of the possible greater activity of tinidazole against G. vaginalis are not yet clear. Repeated courses of oral metronidazole may be poorly tolerated and an alternative but equally effective treatment that is better tolerated may be preferable. In comparison to oral metronidazole, cost is clearly an issue as oral metronidazole is considerably cheaper and available in generic form. However where avoidance of oral metronidazole is necessary because of side effects, oral tinidazole is a cost-effective alternative.

Keywords: bacterial vaginosis, tinidazole, metronidazole, Gardnerella vaginalis

 

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Meaning-making of female genital cutting: children’s perception and acquired knowledge of the ritual

Schultz JH, Lien IL

International Journal of Women's Health 2013, 5:165-175

Published Date: 15 April 2013

Newer agents in antiplatelet therapy: a review

Yeung J, Holinstat M

Journal of Blood Medicine 2012, 3:33-42

Published Date: 25 June 2012

Usefulness of serum mass spectrometry to identify women diagnosed with higher grades of cervical intraepithelial neoplasia may differ by race

Matthews R, Azuero A, Asmellash S, Brewster E, Partridge EE, Piyathilake CJ

International Journal of Women's Health 2011, 3:185-192

Published Date: 12 July 2011

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Diagnosis and management of pre-eclampsia: an update

Judi A Turner

International Journal of Women's Health 2010, 2:327-337

Published Date: 30 September 2010

Exacerbation rate, health status and mortality in COPD – a review of potential interventions

Terence AR Seemungal, John R Hurst, Jadwiga A Wedzicha

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:203-223

Published Date: 29 May 2009

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009